tiprankstipranks
Advertisement
Advertisement

EBR Systems Corrects Issued Capital Figures After Reverse Stock Split

Story Highlights
  • EBR Systems corrected its post-reverse-split capital figures, revising CDI, common stock and option counts.
  • The updated figures improve transparency for ASX investors without affecting EBR Systems’ core operations or strategy.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
EBR Systems Corrects Issued Capital Figures After Reverse Stock Split

Claim 55% Off TipRanks

An announcement from EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:EBR) ) is now available.

EBR Systems has corrected an error in its previously reported issued capital figures following a recent reverse stock split, adjusting the counts for common stock, CHESS Depositary Interests and options while leaving warrants unchanged. The revised numbers, which now include CDIs tied to shares on the U.S. register, clarify the company’s post-split capital structure for investors but do not alter its operations or strategic focus in the wireless cardiac pacing market.

The update ensures more accurate disclosure of the company’s equity base on the ASX, which is important for shareholder transparency and valuation assessments. By promptly addressing the discrepancy and confirming the corrected security numbers, EBR Systems reinforces its governance practices as it continues commercial and clinical activities around its WiSE wireless pacing technology.

The most recent analyst rating on (AU:EBR) stock is a Buy with a A$2.43 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.

More about EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh

EBR Systems, Inc. is a Silicon Valley-based medical device company focused on treating cardiac rhythm disease through its proprietary Wireless Stimulation Endocardially (WiSE) technology. The company develops the world’s only wireless, endocardial left-ventricular pacing system, initially targeting heart failure patients requiring Cardiac Resynchronisation Therapy, with future applications envisioned in bradycardia and non-cardiac indications.

Average Trading Volume: 554,592

Technical Sentiment Signal: Sell

Current Market Cap: A$2.93B

See more data about EBR stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1